Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kristensen

Showing results (231-240 of 320) with videos related to

Pageof 32
Sort By:
EMBO Molecular Medicine|August 4, 2016
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancerAldema Sas-Chen, Miriam R Aure, Limor Leibovich, et al.
Oncotarget|December 3, 2016
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survivalThomas Fleischer, Jovana Klajic, Miriam Ragle Aure, et al.
Journal of Medical Genetics|July 5, 2013
Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast sizeJingmei Li, Jia Nee Foo, Nils Schoof, et al.
Genome Biology|November 22, 2013
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsMiriam Ragle Aure, Suvi-Katri Leivonen, Thomas Fleischer, et al.
Nature Communications|December 5, 2019
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironmentXavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, et al.
Nature Communications|November 2, 2017
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Nature Communications|December 19, 2018
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
NPJ Breast Cancer|September 11, 2021
Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3<sup>VNTR</sup> polymorphisms and gene co-expressionJaume Fores-Martos, Raimundo Cervera-Vidal, Julia Sierra-Roca, et al.
Nature Communications|January 30, 2019
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Genome Biology|December 10, 2016
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencingJonas Demeulemeester, Parveen Kumar, Elen K Møller, et al.
Pageof 32

Showing results (231-240 of 320) with videos related to

Sort By:
Pageof 32
EMBO Molecular Medicine|August 4, 2016
LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancerAldema Sas-Chen, Miriam R Aure, Limor Leibovich, et al.
Oncotarget|December 3, 2016
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survivalThomas Fleischer, Jovana Klajic, Miriam Ragle Aure, et al.
Journal of Medical Genetics|July 5, 2013
Large-scale genotyping identifies a new locus at 22q13.2 associated with female breast sizeJingmei Li, Jia Nee Foo, Nils Schoof, et al.
Genome Biology|November 22, 2013
Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsMiriam Ragle Aure, Suvi-Katri Leivonen, Thomas Fleischer, et al.
Nature Communications|December 5, 2019
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironmentXavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, et al.
Nature Communications|November 2, 2017
Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Nature Communications|December 19, 2018
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
NPJ Breast Cancer|September 11, 2021
Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3<sup>VNTR</sup> polymorphisms and gene co-expressionJaume Fores-Martos, Raimundo Cervera-Vidal, Julia Sierra-Roca, et al.
Nature Communications|January 30, 2019
Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressorsJiqiu Cheng, Jonas Demeulemeester, David C Wedge, et al.
Genome Biology|December 10, 2016
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencingJonas Demeulemeester, Parveen Kumar, Elen K Møller, et al.
Pageof 32